X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ORCHID PHARMA LTD AJANTA PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 21.1 -0.8 - View Chart
P/BV x 9.1 0.6 1,610.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 AJANTA PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
ORCHID PHARMA LTD
Sep-13
AJANTA PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,720194 886.6%   
Low Rs1,10335 3,151.4%   
Sales per share (Unadj.) Rs194.6276.5 70.4%  
Earnings per share (Unadj.) Rs45.2-79.2 -57.1%  
Cash flow per share (Unadj.) Rs50.3-43.5 -115.8%  
Dividends per share (Unadj.) Rs8.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs132.053.9 244.8%  
Shares outstanding (eoy) m88.7770.45 126.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x7.30.4 1,751.3%   
Avg P/E ratio x31.2-1.4 -2,159.4%  
P/CF ratio (eoy) x28.1-2.6 -1,065.0%  
Price / Book Value ratio x10.72.1 503.6%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m125,2998,067 1,553.3%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,5702,527 101.7%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m17,27519,477 88.7%  
Other income Rs m166407 40.8%   
Total revenues Rs m17,44219,884 87.7%   
Gross profit Rs m5,8071,103 526.7%  
Depreciation Rs m4512,519 17.9%   
Interest Rs m495,227 0.9%   
Profit before tax Rs m5,474-6,236 -87.8%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m1,460-125 -1,166.1%   
Profit after tax Rs m4,014-5,580 -71.9%  
Gross profit margin %33.65.7 593.8%  
Effective tax rate %26.72.0 1,328.4%   
Net profit margin %23.2-28.7 -81.1%  
BALANCE SHEET DATA
Current assets Rs m7,63911,014 69.4%   
Current liabilities Rs m2,71532,060 8.5%   
Net working cap to sales %28.5-108.1 -26.4%  
Current ratio x2.80.3 819.1%  
Inventory Days Days4395 45.6%  
Debtors Days Days7934 234.4%  
Net fixed assets Rs m6,91429,440 23.5%   
Share capital Rs m177705 25.1%   
"Free" reserves Rs m11,4422,043 560.2%   
Net worth Rs m11,7213,800 308.4%   
Long term debt Rs m1499,018 1.6%   
Total assets Rs m14,81446,510 31.9%  
Interest coverage x112.9-0.2 -58,483.2%   
Debt to equity ratio x02.4 0.5%  
Sales to assets ratio x1.20.4 278.5%   
Return on assets %27.4-0.8 -3,608.5%  
Return on equity %34.2-146.9 -23.3%  
Return on capital %46.5-3.7 -1,245.9%  
Exports to sales %55.137.9 145.6%   
Imports to sales %6.022.6 26.6%   
Exports (fob) Rs m9,5277,378 129.1%   
Imports (cif) Rs m1,0384,406 23.5%   
Fx inflow Rs m10,4227,513 138.7%   
Fx outflow Rs m1,6785,649 29.7%   
Net fx Rs m8,7441,865 469.0%   
CASH FLOW
From Operations Rs m3,2641,682 194.1%  
From Investments Rs m-2,093-9,860 21.2%  
From Financial Activity Rs m-1,1866,644 -17.8%  
Net Cashflow Rs m-15-1,535 1.0%  

Share Holding

Indian Promoters % 73.8 32.3 228.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 4.6 33.7%  
FIIs % 7.6 3.3 230.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 17.0 55.3 30.7%  
Shareholders   20,968 84,811 24.7%  
Pledged promoter(s) holding % 4.4 54.9 8.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - J.B.CHEMICALS COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS